Arsenic trioxide (As 2 O 3 ) has been found to induce apoptosis in leukemia cell lines and clinical remissions in patients with acute promyelocytic leukemia. In this study, we investigated the cytotoxic effect and mechanisms of action of As 2 O 3 in human tumor cell lines. As 2 O 3 caused inhibition of cell growth (IC 50 range, 3-14 M) in a variety of human solid tumor cell lines, including four human non-small-cell lung cancer cell lines (H460, H322, H520, H661), two ovarian cancer cell lines (SK-OV-03, A2780), cervical cancer HeLa, and breast carcinoma MCF-7, as assessed by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay. Flow cytometry analysis showed that As 2 O 3 treatment resulted in a time-dependent accumulation of cells in the G 2 /M phase. We observed, using WrightGiemsa and 4Ј,6-diamidine-2-phenylindole-dihydrochloride staining, that As 2 O 3 blocked the cell cycle in mitosis. In vitro examination revealed that As 2 O 3 markedly promoted tubulin polymerization without affecting GTP binding to ␤-tubulin. Immunocytochemical and EM studies of treated MCF-7 cells showed that As 2 O 3 treatment caused changes in the cellular microtubule network and formation of polymerized microtubules. Similar to most anti-tubulin agents, As 2 O 3 treatment induced up-regulation of the cyclin B1 levels and activation of p34 cdc2 /cyclinB1 kinase, as well as Bcl-2 phosphorylation. Furthermore, activation of caspase-3 and -7 and cleavage of poly-(ADP-ribose) polymerase and ␤-catenin occurred only in As 2 O 3 -induced mitotic cells, not in interphase cells, suggesting that As 2 O 3 -induced mitotic arrest may be a requirement for the activation of apoptotic pathways. In addition, As 2 O 3 exhibited similar inhibitory effects against parental MCF-7, P-glycoprotein-overexpressing MCF-7/doxorubicin cells, and multidrug resistance protein (MRP)-expressing MCF-7/etoposide cells (resistance indices, 2.3 and 1.9, respectively). Similarly, As 2 O 3 had similar inhibitory effect against parental ovarian carcinoma A2780 cells and tubulin mutation paclitaxel-resistant cell lines PTx10 and PTx22 (resistance indices, 0.86 and 0.93, respectively), suggesting that its effect on tubulin polymerization and G 2 /M phase arrest is distinct from that of paclitaxel. Taken together, our data demonstrate that As 2 O 3 has a paclitaxel-like effect, markedly promotes tubulin polymerization, arrests cell cycle at mitosis, and induces apoptosis. In addition, As 2 O 3 is a poor substrate for transport by P-glycoprotein and MRP, and non-cross-resistant with paclitaxel resistant cell lines due to tubulin mutation, suggesting that As 2 O 3 may be useful for treatment of human solid tumors, particularly in patients with paclitaxel resistance.
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Recent evidence has indicated that arsenic trioxide (As 2 O 3 ) is able to induce clinical remissions in patients with acute promyelocytic leukemia (APL) Look, 1998; Shao et al., 1998; Soignet et al., 1998) . In addition, several investigators have shown that As 2 O 3 induces programmed cell death in APL cell lines with APL/RA proteins. Although the mechanisms by which As 2 O 3 induces apoptosis remain to be further elucidated, some evidence indicated that this compound can down-regulate Bcl-2 protein and activate caspase-3-like caspase activity (Chen et al., 1996 (Chen et al., , 1998 Kroemer and de The, 1999) . Some investigators have shown that As 2 O 3 -induced apoptosis is caused by a direct effect on the mitochondrial permeability transition pore and loss of the mitochondrial transmembrane potential (Zhu et al., 1999) .
Microtubules are critical elements in a wide variety of fundamental functions, including sustained cell shape, cellular transportation of vesicles and protein complexes, and regulation of cell motility, as well as of cell division (Hyams and Lloyd, 1993; Margolis and Wilson, 1998) . During mitosis, microtubules are at the highest dynamic instability for re-sponse to the formation of spindles and separation of chromosomes. Because microtubules play crucial roles in the regulation of the mitotic apparatus, disruption of microtubules can induce cell-cycle arrest in M-phase, formation of abnormal mitotic spindles, and final triggering of the signals for programmed cell death (Mitchison, 1988) . Agents such as the vinca alkaloids and the taxanes, which affect the dynamics of microtubules, have emerged as useful therapeutic agents for the treatment of human cancer (Rowinsky and Donehower, 1991; Jordan et al., 1992) . Recently, some reports indicated that As 2 O 3 treatment resulted in cell-cycle arrest at either G 1 or G 2 /M phase depending on the cell lines (Ma et al., 1998; Perkins et al., 2000) . In addition, Li and Broome reported that As 2 O 3 treatment resulted in cell-cycle progression arrest at metaphase in myeloid leukemia cells through noncompetitive disruption of GTP binding to ␤-tubulin and inhibition of GTP-induced tubulin polymerization (Li and Broome, 1999) .
Although a number of studies have demonstrated that As 2 O 3 has potent activity against cell growth in a series of leukemia cell lines, little information is available regarding this compound's effect on cell growth in solid tumor cell lines (Seol et al., 1999; Meada et al., 2001) . In this study, we investigated the effect of As 2 O 3 on cell proliferation in human solid tumor cell lines, particularly breast, ovary, and lung. Moreover, we also investigated the molecular basis of As 2 O 3 -induced cell cycle arrest and apoptosis in human breast carcinoma MCF-7 cells and NSCLC H460 cells. Interestingly, we found that As 2 O 3 treatment led to the accumulation of cells in mitosis, and the induction of apoptosis. Further studies showed that As 2 O 3 caused a paclitaxel-like concentrationdependent promotion of tubulin polymerization in vitro. Morphological and EM observations showed that As 2 O 3 caused changes in the cellular microtubule network.
Because As 2 O 3 had a paclitaxel-like effect, it was of great interest to test whether As 2 O 3 could circumvent paclitaxel resistance. The results present herein show that As 2 O 3 is active in paclitaxel resistant cell lines, whether due to overexpression of P-glycoprotein, or MRP, or tubulin mutation.
Overall, our results lead to a better understanding of the unique mechanism of action of As 2 O 3, and provide a suggestion that As 2 O 3 may be of therapeutic value for the treatment of human solid tumors including those with acquired resistance.
Materials and Methods
Cell Culture and Treatment. Human cervical HeLa cells, ovarian cancer SK-OV-03 cells, and human NSCLC cell lines, H460, H322, H520, and H661 were purchased from the American Type Culture Collection (Manassas, VA) and maintained in RPMI 1640 medium supplied with 10% fetal bovine serum. Human breast carcinoma MCF-7 cells, P-glycoprotein-overexpressing MCF-7/Dox cells, and MRP-positive MCF-7/VP-16 cells were maintained in culture as monolayers in minimal essential medium with 10% fetal bovine serum as described previously (Perez-Soler et al., 1997) . Human ovarian carcinoma A2780 cells and the tubulin mutant cell lines resistant to paclitaxel (A2780/PTx10, A2780/PTx22) were kindly provided by Dr. Fojo (National Cancer Institute, National Institutes of Health, Bethesda, MD). A2780 cells were maintained in RPMI 1640 medium with 10% fetal bovine serum, A2780/PTx10 and A2780/ PTx22 cells were maintained in the same medium containing 15 ng/ml of paclitaxel and 5 g/ml of verapamil (Giannakakou et al., 1997) . For determination of cell growth inhibition, cells were plated at 1 ϫ 10 4 cells/well in 96-well microplates and exposed to varying concentrations of As 2 O 3 and paclitaxel at 37°C for 72 h. At the end of drug exposure, 10 l of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide solution (5 mg/ml) was directly added to each cell culture well and the plates were incubated at 37°C for 2 h. The formazan converted from tetrazolium salt by viable cells was solubilized by 100 l of lysis solution containing 20% SDS and 50% dimethyl formamide (Sigma-Aldrich, St. Louis, MO), and measured in a microplate reader (Dynex Technologies, Chantilly, VA) at 570 nm as described by Hansen et al. (1989) . The IC 50 value resulting from 50% inhibition of cell growth was calculated graphically as a comparison with the control.
Reagents. As 2 O 3 was purchased from Sigma Chemical Inc. (St. Louis, MO), and dissolved in 10% NaOH as 20 mM stock solution. Paclitaxel was purchased from Hande Tech Development USA, Inc. (Houston, TX) and dissolved in dimethyl sulfoxide as 1 mM stock solution. Monoclonal anti-cdc-2, anti-cyclin B1, and anti-Bcl-2 antibodies were purchased from Oncogene Science (Cambridge, MA). Anti-␤-tubulin antibody was obtained from Biogenex Co. (San Ramon, CA). Anti-PARP and anti-␤-catenin antibodies were purchased from BD PharMingen (San Diego, CA). All other chemicals were purchased from Sigma-Aldrich.
Apoptosis Assay. Cells were treated with As 2 O 3 for the indicated time. The attached and detached cells were harvested from culture, and stained with DAPI. The cells with nuclear breakage were manually counted by fluorescence microscopy. For assay of DNA fragmentation, cells were treated with As 2 O 3 for the indicated time. After treatment, cells were harvested from culture and lysed with lysis buffer containing 0.5% Triton X-100, 100 mM Tris-HCl, pH 7.5, and 25 mM EDTA at 4°C for 60 min. After centrifugation at 15,000g for 10 min, the supernatants were collected and treated with 100 g/ml of RNase I and 100 g/ml of proteinase K at 50°C for 30 min, and with phenol and chloroform. The fragmented DNA was precipitated in the presence of sodium acetate and ethanol, dissolved in Tris/EDTA buffer, and then subjected to 1% agarose gel. After electrophoresis, DNA was stained with ethidium bromide and visualized by UV light illumination.
Cell Cycle Analysis. Cells were washed with PBS and fixed with cold 75% ethanol overnight. The fixed cells were incubated with 5 g/ml of RNase I and 1 g/ml of propidium iodide for 6 h, and then cellular DNA content was determined in a flow cytometer. For quantitative assay of mitotic cells, after staining with Wright-Giemsa dye, at least 100 mitotic cells and those with chromosome condensation were counted.
Tubulin Assembly. Purified tubulin from calf brain was purchased from Sigma-Aldrich. The effects of As 2 O 3 on the microtubule assembly-disassembly process were determined as described previously (Jiang et al., 1998b ). For assembly assay, 100 l of tubulin solution (500-600 g of protein/ml) was mixed gently with 400 l of reaction buffer containing 0.1 M MES, 1 mM EGTA, 0.5 mM MgCl 2 , 0.1 mM EDTA, and 2.5 M glycerol at 37°C. As 2 O 3 (0.5-2 mM) was added to each sample cuvet, together or 30 min before 1 mM GTP. Microtubule assembly was monitored by measuring the change of absorbance at room temperature at 350 nm every 5 min on a spectrophotometer (Ultrospec III; Pharmacia LKB, Uppsala, Sweden) until the assembly was completed. For disassembly assay, As 2 O 3 or paclitaxel were added to a cuvet with polymerized microtubules according to the method as described above, and incubated in ice. Changes in absorbance were monitored at 350 nm for 30 min. An equal amount of solvent was used in control cuvet.
Immunoblot Analysis. Cells were harvested from culture, washed with PBS solution and lysed with buffer containing 50 mM Tris-HCl, pH 7.4, 100 mM NaCl, 1 mM EDTA, 1 mM EGTA, 1 mM DTT, 1 mM phenylmethylsulfonyl fluoride, 0.1% nonylphenoxy polythoxy ethanol, 1% SDS, 5 g/ml of aprotinin, and 5 g/ml of leupeptin. The protein amount in each sample was determined with a Bio-Rad DC protein assay kit (Bio-Rad, Hercules, CA). Equal amounts of lysate were loaded on a 12.5% SDS-polyacrylamide gel. After electrophoresis, proteins were transferred to a nitrocellulose membrane and probed by corresponding antibodies. The protein signals were detected by the enhanced chemiluminescence reaction system according to the manufacturer's recommendation (Amersham Biosciences, Indianapolis, IN). The quantification of protein levels in each sample was performed by laser scanner densitometer (GS-670 scanning densitometer; Bio-Rad).
Histone H1 Kinase Assay. After treatment with As 2 O 3 , cells were harvested, washed with PBS solution, and lysed with buffer as described above except for the addition of 1% SDS. Lysate was centrifuged at 15,000g for 10 min, and the supernatant was harvested for immunoprecipitation. Cdc2/cyclin B1 complex was immunoprecipitated by monoclonal anti-cdc2 and cyclin B1 antibodies at 0 to 4°C overnight, and cdc2/cyclin B1 kinase activity was measured by [␥- 32 P]ATP incorporation into the substrate histone H1 as described previously (Ling et al., 1996) .
Caspase Activity Assay. Cells (2 ϫ 10 6 ) were lysed with 50 l of lysis buffer containing 50 mM HEPES, pH 7.4, 0.1% CHAPS, 1 mM DTT, and 0.1 mM EDTA at 0 to 4°C for 5 min. After centrifugation at 15,000g for 15 min, the supernatant was harvested and added to 100 l of reaction mixture containing 50 mM HEPES, pH 7.4, 100 mM NaCl, 0.1% CHAPS, 10 mM DTT, 1 mM EDTA, 10% glycerol, and 2 mM caspase substrates, which were Ac-Asp-Glu-Val-Asp-pNA for caspase-3, Ac-Tyr-Val-Ala-Asp-pNA for caspase-1, Ac-Ile-Glu-ThrAsp-pNA for caspase-8, and Ac-Leu-Glu-His-Asp-pNA for caspase-9. After incubation at 37°C for 120 min, caspase activity was assessed by measurement at 405 nm of pNA release from the substrate.
Immunocytochemical Study. Cells were fixed with cold methanol at Ϫ20°C for 5 min, and washed with PBS solution. Cells were blocked with 1% bovine serum albumin PBS solution for 30 min, and incubated with monoclonal anti-␤-tubulin antibody (1:100) at room temperature for 90 min. After washing three times with PBS solution, cells were reincubated with fluorescein isothiocyanate-conjugated second antibody (1:500) in the dark room for 30 min. Cellular microtubules were observed with a Nikon PS200 fluorescence microscope.
Electron Microscopy. MCF-7 cells were treated with 3 M As 2 O 3 or with the same volume of PBS solution as control. After 12 h, cells were collected and washed twice with PBS solution. Cells were then fixed with osmium tetroxide, dehydrated with an ascending series of ethanol and propylene oxide, and embedded in Araldite. Thin sections were collected on Quick-Coat (Electron Microscopy Sciences, Fort Washington, PA), and treated with copper grids. After staining with uranyl acetate and lead citrate, samples were viewed at 80 kV on a JEOL 1200 EX electron microscope.
Results

Effect of As 2 O 3 on Growth and Apoptosis in Human
Solid Tumor Cells. The initial experiments were conducted for evaluation of As 2 O 3 -induced anti-proliferation in various human sold tumor cell lines. Human ovarian cancer A2780 and breast carcinoma MCF-7 cells exhibited the highest susceptibility to As 2 O 3 , with an IC 50 ϳ3.0 M. Cell lines of cervical (HeLa) and ovarian carcinoma (SK-OV-03) were slightly less sensitive (IC 50 , 4.28 to 4.61 M). NSCLC H520, H322, and H460 cells displayed the lowest susceptibility (IC 50 , Ͼ10 M) ( Table 1) . Next, we examined whether the inhibition of cell growth by As 2 O 3 could be caused by apoptotic death. MCF-7 cells were treated with 3 M As 2 O 3 for the times indicated in Fig. 6 . As 2 O 3 -induced apoptosis was determined both by DAPI staining of cells with nuclear breakage and by DNA fragmentation. As shown in Fig. 1A , only ϳ2 to 5% of cells were apoptotic at 24 h of exposure, ϳ18% of cells were apoptotic by 36 h, and ϳ52% were apoptotic after 72 h of exposure. A similar time pattern of drug-induced apoptosis was found by DNA fragmentation assay using agarose gel electrophoresis (Fig. 1B) .
Effect of As 2 O 3 on Cell Cycle. As 2 O 3 treatment resulted in a time-dependent accumulation of MCF-7 cells in the G 2 /M phase ( Fig. 2A) . At time 0, only ϳ8% of cells were in the G 2 /M phase. After 12 h of treatment, ϳ21% of cells were in the G 2 /M phase. The value of G 2 /M phase cells peaked at 24 h (ϳ52%) and declined thereafter. Similar results were obtained with other cell lines (e.g., H460 and HeLa cells; data not shown). Microscopic examination showed that MCF-7 cells treated with 3 M As 2 O 3 for 24 h led to cell-cycle arrest at metaphase with chromosome condensation and disappearance of the nuclear envelope (Fig. 2B, b) , compared with untreated cells with intact nuclei (Fig. 2B, a) . These results were confirmed by DAPI staining (data not shown). For quantitative analysis of mitotic arrest, cells were stained with Wright-Giemsa, and the percentage of mitotic cells was calculated after counting at least 100 cells. As shown in Fig.  2C , ϳ3% of cells were at M-phase at time 0 and ϳ16% of cells were at M-phase at 12 h. M-phase cells reached peak value (ϳ36%) at 24 h, and declined to ϳ6% after 48 h. Such a pattern for As 2 O 3 -induced M-phase arrest is very similar to that of the paclitaxel-induced M-phase arrest reported previously by us and others (Bhalla et al., 1993; Ling et al., 1998) .
Effect of As 2 O 3 on Tubulin Polymerization in Vitro. Because As 2 O 3 treatment markedly blocked the cell cycle in M-phase, we became interested in testing whether As 2 O 3 could directly affect tubulin. To test this hypothesis, tubulin polymerization and depolymerization in vitro were studied at room temperature in a reaction mixture containing the purified tubulin and GTP, in the presence or absence of As 2 O 3 . The results presented in Fig. 3A , showed that As 2 O 3 significantly promoted tubulin polymerization in a concentration dependent manner. Consequently, we examined whether altered GTP binding to ␤-tubulin could cause As 2 O 3 -induced tubulin polymerization. Tubulin was preincubated with As 2 O 3 at 0°C for 30 min, and then the tubulin polymerization reaction was started by the addition of GTP at room temperature. The results, as shown in Fig. 3B , indicated that pretreatment with As 2 O 3 for 30 min did not affect GTP-promoted tubulin polymerization, indicating that As 2 O 3 -induced tubulin polymerization was not caused by interference with GTP binding domain on ␤-tubulin. Finally, we tested Fig. 3C , both As 2 O 3 and paclitaxel not only prevented the depolymerization of assembled tubulin but also significantly promoted the polymerization of tubulin. In contrast, the polymerized tubulin was gradually and effectively depolymerized at 0°C in the absence of both drugs. The data clearly indicate that As 2 O 3 has a paclitaxel-like effect to promote and stabilize tubulin polymerization in vitro. Effect of As 2 O 3 on Cellular Microtubules. Because strong paclitaxel-like tubulin-stabilizing activity was found in vitro, we tested whether As 2 O 3 treatment affected the cellular microtubule network. MCF-7 cells were treated with 0.5 M paclitaxel, 0.1 M vinblastine, or 3 M As 2 O 3 or with the same volume of PBS solution as control. After 12 h of incubation, the microtubule network was visualized by immunocytochemistry. The microtubule network in control cells exhibited normal arrangement and organization (Fig. 4A) . Treatment with paclitaxel resulted in microtubule polymerization with an increase in the density of cellular microtubules and formation of long thick microtubule bundles surrounding the nucleus (Fig. 4B) . As 2 O 3 treatment resulted in findings similar to those of paclitaxel-induced microtubule changes, such as thickening and increased density of microtubules (Fig. 4C) . In contrast, vinblastine treatment caused cellular microtubule depolymerization with short microtubules in the cytoplasm (Fig. 4D) . To further confirm these results, we used electron microscopy to explore the effect of As 2 O 3 on cellular microtubule structures in MCF-7 cells. As shown in Fig. 5 , the polymerized microtubules with diameters of ϳ25 nm were clearly observed in ϳ40% of As 2 O 3 -treated interphase cells, whereas microtubules with such structure were seen in less than 5% of untreated control cells (Fig. 5A) . Furthermore, we examined the effect of As 2 O 3 on spindle formation in MCF-7 cells, and found that As 2 O 3 treatment caused the formation of abnormal mitotic spindles with a circular pattern, different from paclitaxel treatment, which caused tri-or tetra-polar spindles (data not shown). All results indicated that the microtubule is the intracellular target for As 2 O 3 accounting for the subsequent mitotic arrest and apoptosis.
Effect of As 2 O 3 on P34 cdc2 /Cyclin B Expression and Activity. It is known that the entrance to and exit from M-phase of the cell cycle is regulated by the p34 cdc2 /cyclin B complex. Paclitaxel-induced M-phase arrest is associated with up-regulation and activation of p34 cdc2 /cyclin B kinase in a variety of cell lines (Donaldson et al., 1994) . We determined the effect of As 2 O 3 on expression and activation of cdc2 and cyclin B in MCF-7 cells. As shown in Fig. 6 , treatment with As 2 O 3 resulted in a time-dependent up-regulation of cyclin B1, but did not change cdc2. Histone H1 kinase assay revealed that As 2 O 3 treatment activated p34 cdc2 /cyclin B1 kinase activity in a time-dependent manner. Similar results were obtained in H460 cells, indicating that up-regulation of cyclin B and activation of p34 cdc2 /cyclin B kinase caused by As 2 O 3 is not restricted to MCF-7 cells (data not shown).
Effect of As 2 O 3 on Bcl-2 Phosphorylation. A number of reports have demonstrated that paclitaxel-induced M-phase arrest and apoptosis are associated with Bcl-2 phosphorylation (Blagosklonny et al., 1996; Haldar et al., 1996) . We tested whether As 2 O 3 -induced M-phase arrest and apoptosis were associated with Bcl-2 phosphorylation. MCF-7 and H460 cells were treated with As 2 O 3 for the time indicated in Fig. 7 , and Bcl-2 phosphorylation was detected by immunoblotting analysis. As expected, As 2 O 3 treatment resulted in a time-dependent Bcl-2 phosphorylation in both MCF-7 and H460 cells (Fig. 7) . To explore whether As 2 O 3 -induced Mphase arrest and Bcl-2 phosphorylation could initiate apoptotic pathways, H460 cells were exposed to 10 M As 2 O 3 for 24 h. The mitotic cells (detached cells) and interphase cells (attached cells) were separated as described under Materials and Methods. After being washed three times with drug-free medium, the attached and detached cells were reincubated in fresh drug-free medium for the indicated time. Samples taken from the culture were divided into two parts, one for counting mitotic and apoptotic cells by Wright-Giemsa and DAPI staining, the other for determining mitotic and apopto- Fig. 1 . As 2 O 3 induces apoptosis in MCF-7 cells. A, log-phase growing cells were treated with 3 M As 2 O 3 for the indicated time points. After treatment, cells were harvested, fixed with 75% cold ethanol, and stained with 1 g/ml of DAPI for 1 h. The apoptotic cells with nuclear breakage at least 100 cells were counted by fluorescence microscopy. Each point represents the mean Ϯ S.D. of three independent experiments. B, As 2 O 3 induces DNA laddering fragmentation. MCF-7 cells were treated with 3 M As 2 O 3 for the indicated time. After treatment, cells were lysed with lysis buffer, and DNA was extracted as described under Materials and Methods. DNA was dissolved in TE buffer, and subjected to electrophoresis in a 1% agarose gel. DNA laddering was visualized by UV light illumination. tic events by immunoblotting analysis. As shown in Fig. 8 , ϳ97% of detached cells were in M-phase at time 0. By 10 h of incubation, ϳ76% of cells were in M-phase; only ϳ4% were in M-phase at 24 h. In the detached cells, ϳ3% of the cells were apoptotic at time 0, which gradually increased to ϳ70% after 24 h of incubation. Furthermore, the immunoblotting analysis revealed that Bcl-2 phosphorylation bands in detached cells were clearly detected at time 0 but disappeared after 24 h of incubation. The cleavage bands of PARP and ␤-catenin were seen as early as 10 h and increased as incubation continued. In contrast, neither accumulation of mitotic or Fig. 2 . Effect of As 2 O 3 on cell cycle progression. A, MCF-7 cells were treated with 3 M As 2 O 3 for the indicated time points. After treatment, cells were fixed with 75% ethanol overnight, and incubated with 5 g/ml of RNase I, and 1 g/ml of propidium iodide for 6 h. DNA content was assessed by a flow cytometer. Each point represents the mean Ϯ S.D. of three independent experiments. B, morphological examination of As 2 O 3 -induced M-phase arrest. MCF-7 cells were treated with 3 M As 2 O 3 or with the same volume of PBS solution as control. After 24 h of incubation, cells were harvested and stained with Wright-Giemsa. In As 2 O 3 -treated cells, typical metaphase arrest cells presented with condensed and separated chromosomes (b), whereas control cells were in interphase with intact nuclei (a). C, quantitative assessment of mitotic arrest by As 2 O 3 . MCF-7 cells were treated with 3 M As 2 O 3 for the indicated time. Cells were stained with Wright-Giemsa, and the mitotic cells were counted at least 100 cells. Each point represents the mean Ϯ S.D. of three independent experiments. Fig. 3 . Effect of As 2 O 3 on microtubule polymerization in vitro. A, As 2 O 3 promotes tubulin assembly. Purified bovine tubulin was incubated at 37°C in reaction mixtures containing 1 mM GTP, different concentrations of As 2 O 3 , and the same volume of solvent (10% NaOH) as control. Tubulin polymerization was determined by measuring observance at 350 nm. B, As 2 O 3 does not affect GTP-promoted tubulin polymerization. Tubulin was pretreated with 1 mM As 2 O 3 or with the same volume of solvent as control at 0°C for 30 min, then tubulin polymerization reaction was started by addition of 1 mM GTP at 37°C, and tubulin polymerization was measured as described above. C, like paclitaxel, As 2 O 3 prevents against microtubule depolymerization. Tubulin was polymerized in the presence of 1 mM GTP at 37°C for 20 min. The polymerized tubulin was incubated with 1 mM As 2 O 3 , 10 M paclitaxel, or with the same volume of solvent as control, and the depolymerization was performed at 0°C and monitored by measuring the absorbance value at 350 nm. Each point represents the mean value of two independent experiments. RT, room temperature. molpharm.aspetjournals.org apoptotic cells, Bcl-2 phosphorylation, cleavage of PARP, nor ␤-catenin was observed in attached cells. In addition, the activation of caspases (Fig. 8C ) and the cleavage of procaspase-3 and -7 into the active forms (Fig. 8D) were found in detached cells as early as 10 h of incubation. The activation of caspase-3 and -7, as well as the cleavage of apoptosisrelated proteins, occurred only in detached cells and as early as 10 h of incubation; by that time, ϳ75% of cells were still at mitosis and only ϳ20% were apoptotic. Thus, it is presumed that As 2 O 3 -induced M-phase arrest precedes initiation of apoptotic pathways and may be prerequisite.
Effect of As 2 O 3 and Paclitaxel on Cell Proliferation in Drug-Resistant Cell Lines. Because As 2 O 3 has paclitaxel-like activity against cell proliferation in human solid tumors, we examined whether this compound was cross resistant with paclitaxel in drug resistant cell lines. We treated parental breast cancer MCF-7 cells, P-glycoprotein-overexpressing MCF-7/Dox cells, and MRP-positive MCF-7/VP-16 cells with As 2 O 3 and with paclitaxel for 72 h, and then determined the drug-induced cytotoxicities of each. As shown in Table 2 , the resistance index (RI) values for paclitaxel and As 2 O 3 in MCF-7/Dox cell lines were 35 and 2.3, respectively. The RI values for paclitaxel and As 2 O 3 in MCF-7/VP-16 cell line were 4 and 1.9, respectively. These data indicate that As 2 O 3 , unlike paclitaxel, was a poor substrate for transport by both P-glycoprotein and MDR protein. Next we tested the cytotoxic effect of As 2 O 3 and paclitaxel in parental ovarian cancer cell line (A2780) and its tubulin mutation paclitaxel resistant cell lines (A2780/PTx10, and A2780/PTx22). The results showed that RI values for paclitaxel were 15 and 17 in A2780/PTx10 and A2780/PTx22 cells, whereas the RI values were Ͻ1 for As 2 O 3 in both tubulin mutant cell lines. These results clearly show that As 2 O 3 is not cross-resistant with paclitaxel.
Discussion
Our data demonstrate that As 2 O 3 is efficacious in inhibiting the proliferation of various models of human solid tumors. As 2 O 3 -induced cytotoxicity was independent of p53 status, suggesting that As 2 O 3 -induced cell death does not occur via p53-dependent pathways. We found that As 2 O 3 was a poor substrate for transport by P-glycoprotein or by MRP, suggesting that pumping out intracellular As 2 O 3 may not be a major factor in explaining the different susceptibilities to As 2 O 3 of different cell lines . These differences remain unexplained. One possibility could be due to different cellular components and/or thresholds in different cell lines for apoptotic signaling. The IC 50 value for As 2 O 3 in MCF-7 breast carcinoma and A2780 ovarian carcinoma cell lines was about 3 M, a concentration very close to effective serum concentration for successfully treating patients with acute promyelocytic leukemia in the clinic (Shen et al., 1997) . Thus it is suggested that As 2 O 3 might be useful for the treatment of some instances of human breast and ovarian cancers. In addition, we found that As 2 O 3 lacked cross-resistance in both P-glycoprotein-and MRP-overexpressing cell lines. Furthermore, there is no cross-resistance between As 2 O 3 and paclitaxel in two cell lines resistant to paclitaxel because of tubulin mutation, suggesting that it might be useful for treating drug-refractory patients, particularly those with paclitaxel resistance.
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As 2 O 3 induces cell death remains poorly understood. Recently, some investigators reported that As 2 O 3 caused DNA damage, oxidative stress, and mitochondrial dysfunction (Van Wijk et al., 1988; Dong and Lou, 1993; Gurr et al., 1999; Yih and Lee, 2000) . In addition, As 2 O 3 treatment blocked the cell cycle in G 1 or at G 2 /M depending on the cell line (Ma et al., 1998; Li and Broome, 1999) . In the present study, we found that As 2 O 3 treatment resulted in cell-cycle arrest at M-phase in MCF-7, H460, and HeLa cells. These results are consistent with the report by Li and Broome, who reported that As 2 O 3 treatment led to metaphase arrest in myeloid leukemia cells (Li and Broome, 1999) . Our results demonstrate that As 2 O 3 -induced M-phase arrest is due to interaction with tubulin, resulting in tubulin polymerization. We also found that tubulin polymerization by As 2 O 3 did not affect GTP binding to ␤-tubulin. These results, however, are diametrically opposite those of Li and Broome, who reported that As 2 O 3 caused blockade of GTP binding to ␤-tubulin and cdc2 /cyclin B complex in MCF-7 cells. A, MCF-7 cells were treated with 3 M As 2 O 3 for the indicated time and then cell extracts were prepared for immunoblot analysis. Equal amounts of extract from each sample were electrophoresed on 12% SDS-PAGE. After transfer to a nitrocellulose membrane, cdc2 and cyclin B were probed by monoclonal anti-cdc2, and anti-cyclin B antibodies. The quantification of cdc2 and cyclin B was determined by laser densitometry (S-670 Scanning Densitometer; BioRad). The relative amounts of cdc2 and cyclin B were expressed as the amount compared with that at time 0. B, MCF-7cells were treated with 3 M As 2 O 3 for the indicated time. After treatment, cells were harvested and lysed with lysis buffer. Cdc2/cyclin B complexes were immunoprecipitated by monoclonal anti-cdc2 and anti-cyclin B antibodies, and protein A/G-conjugated agarose beads. Activity of cdc2/ cyclin B kinase was determined by [␥- 32 P]ATP incorporation into the substrate histone H1. The kinase activity was determined by either autoradiography, or by counting the radioactivity in histone H1 protein.
The relative kinase activity was expressed as the kinase activity compared with that at time 0. Each point represents mean Ϯ S.D. of three independent experiments As 2 O 3 : Tubulin Polymerization, Mitotic Arrest, and Apoptosis 535 at ASPET Journals on November 7, 2017 molpharm.aspetjournals.org thus inhibited tubulin polymerization (Li and Broome, 1999) . To certify our conclusions, we have performed the test under various conditions, including the addition of As 2 O 3 before, concurrent with, and after GTP, and obtained reproducible results in all cases. Because the ␤-tubulin materials used by us and Li and Broome were both from Sigma-Aldrich, the explanation for contrary results is not obvious. One possibility may be the solvent for As 2 O 3 . In the present work, As 2 O 3 was dissolved in 10% NaOH, which was also used in the drug-free control. The solvent used in Li and Broome's experiment is not clearly described, and this could be a difference.
In this work, we noticed a big discrepancy between the concentrations of As 2 O 3 in cell-based assays and in cell-free systems. We believe that the intracellular circumstances may provide an ideal environment for the reaction of As 2 O 3 with the microtubule assembly process and that the reaction conditions of the widely used cell-free microtubule assemblydisassembly assays might not facilitate the As 2 O 3 -microtubule interaction; consequently, the concentration of As 2 O 3 in this system must be much higher than that in the cell-based assays. As a matter of fact, this phenomenon has been observed before by us using other tubulin ligands, although the discrepancies were not so pronounced (Jiang et al., 1998a,b) .
Indirect immunofluorescence techniques allow detection of morphological changes in the microtubule network, such as alterations in microtubule organization and arrangement. The changes in microtubule length and density constitute an appropriate system to qualitatively assess the intracellular microtubule polymerization or depolymerization caused by antitubulin agents (de Arruda et al., 1995; Mooberry et al., 1999) . The results from tubulin depolymerization experiments indicated that As 2 O 3 treatment prevented tubulin depolymerization, which was similar to the effect of paclitaxel treatment. To further confirm these results, changes in the cellular microtubule network were observed immunocyto- MCF-7 and H460 cells were treated with 3 or 10 M As 2 O 3 , respectively, for the indicated time. Cells were harvested, and cell extract was prepared and loaded on 14% SDS-PAGE as described under Materials and Methods. After electrophoresis, protein blots were transferred on the nitrocellulose membrane, and Bcl-2 protein was probed by monoclonal anti-Bcl-2 antibody. chemically. We found that the effect of As 2 O 3 was similar to that of paclitaxel but different from that of vinblastine. Thick bundles of microtubule network surrounding the nucleus were seen in As 2 O 3 -and paclitaxel-treated cells, whereas shortened depolymerized microtubules were observed in vinblastine-treated cells. Details of the bundles of As 2 O 3 -induced microtubule were studied by electron microscopy. As 2 O 3 treatment caused the formation of filament tubular structures ϳ25 nm in diameter. These structures were rarely seen in interphase control cells.
Antitubulin compounds can be classified into categories depending on their binding sites on ␤-tubulin. Vinca alkaloids, rhizoxin, dolastetins, and spongistatin react with the domain for "vinblastine"; colchicine, nocodazole, podophyllotoxin, steganacin, and curacin A bind to the "colchicine" domain (Bai et al., 1993; Uppuluri et al., 1993; Lobert et al., 1995) . Paclitaxel interacts with amino acids 1 to 31 and 217 to 231 at the N terminus of ␤-tubulin (Rao et al., 1994 (Rao et al., , 1995 ; the main interaction of the paclitaxel ring with tubulin is at L279 at the B8 -H9 loop (Nogales et al., 1998) , and GTP/GDP adheres at the GTP binding sites (Little and Luduena, 1987) . Because preincubation of ␤-tubulin with As 2 O 3 did not prevent GTP-dependent assembly of microtubules, it suggests that the As 2 O 3 binding site probably is separate from the GTP pocket. Because As 2 O 3 exhibited actions on the tubulinmicrotubule cycle similar to paclitaxel, As 2 O 3 and paclitaxel might share a common binding domain on ␤-tubulin. We examined the effect of As 2 O 3 on [ 3 H]paclitaxel binding to ␤-tubulin by competition assay as described by Bollag et al. (1995) . The results from competitive inhibition experiments showed, however, that As 2 O 3, even at high concentrations, did not competitively inhibit [ 3 H]paclitaxel binding to ␤-tubulin (data not shown), indicating that As 2 O 3 does not share paclitaxel binding sites on ␤-tubulin. Furthermore, the results presented in Table 2 show that there is no cross-resistance between As 2 O 3 and paclitaxel in paclitaxel-resistant cell lines due to tubulin mutation, further supporting the interpretation that As 2 O 3 has its own binding site on ␤-tubulin.
In eukaryotic cells, cell-cycle progression is regulated although timely activation and inactivation of cyclin-dependent kinases, cyclins, and other regulatory factors. Inappropriate alteration in the expression or/and activation of cyclindependent kinases and regulators can lead to blockade of cell cycle progression and induction of programmed cell death (Pines, 1995) . It is well known that p34 cdc2 /cyclin B complexes are involved in regulation of G 2 /M phase and the M-phase transition (King et al., 1994) . Our previous work and that of others have demonstrated that paclitaxel-induced M-phase arrest, inappropriate accumulation of B type cyclins and activation of p34 cdc2 /cyclin B kinase was associated with the initiation of apoptotic pathways. In the present study, we found that As 2 O 3 treatment led to an increase in cyclin B level and stimulation of p34 cdc2 /cyclin B kinase activity. The pattern of As 2 O 3 -induced activation of p34 cdc2 /cyclin B and apoptosis is similar to that of paclitaxel, as we described previously . Our results indicate that in addition to direct disruption of tubulin, treatment with As 2 O 3 can lead to inappropriate accumulation and/or activation of G 2 /M phase-related regulators, resulting in the initiation of apoptosis signaling.
Recently, a number of investigators indicated that antitubulin agents are able to induce Bcl-2 phosphorylation (Jiang et al., 1998a; Tahir et al., 2001) . The role of Bcl-2 phosphorylation in G 2 /M phase arrest and in apoptosis remains to be further elucidated (Yamamoto et al., 1999) . Our previous results indicated that some anti-tubulin agents, such as nocodazole, induced Bcl-2 phosphorylation that correlated only with M-phase arrest. Paclitaxel-induced Bcl-2 phosphorylation was associated with the initiation of apoptosis, however (Ling et al., 1998b) . As 2 O 3 treatment, like that of most antitubulin agents, resulted in Bcl-2 phosphorylation in MCF-7 and H460 cells. As 2 O 3 -induced apoptotic events including the activation of caspases and proteolysis of apoptotic target proteins occurred only in drug-induced mitotic cells, not in interphase cells. A time-course study showed that As 2 O 3 -induced Bcl-2 phosphorylation preceded by 10 h the activation of caspase-3 and -7 and cleavage of PARP and ␤-catenin, suggesting that As 2 O 3 -induced M-phase arrest and Bcl-2 phosphorylation might be a required event for the initiation of apoptosis. Recent reports indicate that antitubulin agent blockage of the cell cycle at M-phase can be associated with the activation of several types of kinases, leading to the phosphorylation of cascades, and the activation of cdc2/cyclin B kinase, cdc-25, Raf, and Bcl-2 phosphorylation (Scatena et al., 1998; Fang et al., 2000) . To explore the kinases that might be involved in As 2 O 3 -induced Bcl-2 phosphorylation, we used pharmacological concentrations of kinase inhibitors to test their effect on drug-induced M-phase arrest and Bcl-2 phosphorylation. Preliminary data show that the protein kinase C inhibitor staurosporine at 50 nM effectively prevented As 2 O 3 -induced Bcl-2 phosphorylation and M-phase arrest; the cdc2 kinase inhibitor roscovitine partially inhibited Bcl-2 phosphorylation. However, the tyrosine kinase inhibitor genistein and the mitogen-activated protein kinase inhibitor PD98059 had no effect on Bcl-2 phosphorylation (unpublished data). These data suggest that the activation of some specific kinases, such as protein kinase C, could be responsible for As 2 O 3 -induced Bcl-2 phosphorylation and M-phase arrest.
In summary, our data demonstrate that As 2 O 3 is efficacious in suppressing the cell growth in a variety of solid tumor models. As 2 O 3 directly interferes with microtubules, blocking cell cycle at the M-phase. These effects are paclitax- 
